Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis

Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis

PurposeTaxanes are widely used in gynecological cancer therapy, however, taxane-induced peripheral neuropathy (TIPN) limits chemotherapy dose and reduces patients’ quality of life. As a safe and convenient intervention, cryotherapy has been recommended as a promising intervention in the recent clini...

Full description

Bibliographic Details
Main Authors:	Junting Jia, Yimeng Guo, Raghav Sundar, Aishwarya Bandla, Zhiying Hao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Oncology
Subjects:	cryotherapy prevention taxane peripheral neuropathy meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.781812/full

Similar Items

Prevention of Oxaliplatin-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis
by: Siyu Peng, et al.
Published: (2022-02-01)

Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-02-01)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-06-01)

Supplemental Preparations in Taxane-Induced Neuropathy Management
by: AmirHosein Sanei, et al.
Published: (2023-04-01)

Taxane-Induced Peripheral Neurotoxicity
by: Roser Velasco, et al.
Published: (2015-04-01)

The Future of Chemotherapy: The Mechanisms and Benefits of Exercise in Taxane-Induced Peripheral Neuropathy
by: Sumedha Shastry, et al.
Published: (2023-11-01)

Reliability and Validity of the Turkish Version of Chemotherapy-induced Peripheral Neuropathy Assessment Tool for Breast Cancer Patients Receiving Taxane Chemotherapy
by: Neriman Yükseltürk Simsek, et al.
Published: (2018-01-01)

Classical ayurveda management of TCH (taxane, carboplatin, and herceptin) based chemotherapy induced peripheral neuropathy- A case report
by: Zankhana Buch, et al.
Published: (2024-09-01)

A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
by: Eun Hee Sohn, et al.
Published: (2021-04-01)

Investigating the effect of zinc on the prevention of acute peripheral neuropathy in cancer patients treated with taxanes
by: Ali Haji Gholami, et al.
Published: (2022-01-01)

Efficacy of Multiple Drugs in Preventing Chronic Peripheral Neuropathy Induced by Platinum and Taxane: A Network Meta-analysis
by: LIANG Cuilyu, et al.
Published: (2022-02-01)

Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study
by: Jingtong Zhai, et al.
Published: (2023-02-01)

Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time
by: Mian Wang, et al.
Published: (2019-11-01)

Cropsi study: Efficacy and safety of cryotherapy and cryocompression in the prevention of chemotherapy-induced peripheral neuropathy in patients with breast and gynecological cancer–A prospective, randomized trial
by: Christine Brunner, et al.
Published: (2024-08-01)

Psychological distress and quality of life in breast cancer survivors with taxane-induced peripheral neuropathy: A scoping review
by: Lauren Schwab, et al.
Published: (2023-01-01)

Prevention of paclitaxel-induced peripheral neuropathy: literature review of potential pharmacological interventions
by: Aalaa Mahmoud Ahmed Shawqi Mahmoud, et al.
Published: (2024-05-01)

View of Perceived Symptoms Associated with Chemotherapy-induced Peripheral Neuropathy in Patients with Breast Cancer: A Cross-sectional Study
by: Alper TUĞRAL, et al.
Published: (2024-08-01)

Acetyl-L-carnitine for the prevention of taxane-induced neuropathy in patients with breast cancer: a systematic review and meta-analysis
by: Mahnaz Momenzadeh, et al.
Published: (2023-01-01)

Prevalence and predictors of peripheral neuropathy after breast cancer treatment
by: Mandana Kamgar, et al.
Published: (2021-10-01)

New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy
by: Janet Schloss, et al.
Published: (2016-01-01)

Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients
by: Yuko Tanabe, et al.
Published: (2020-04-01)

Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: A prospective self-controlled trial
by: Yuko Kanbayashi, et al.
Published: (2020-02-01)

The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane-induced sensory neuropathy: A randomized clinical trial
by: Razieh Avan, et al.
Published: (2018-01-01)

Comparison of Clinical Symptoms and Neurophysiological Findings in Patients With Chemotherapy Induced Peripheral Neuropathy
by: Kye Hee Cho, et al.
Published: (2022-06-01)

Impact of Chemotherapy-Induced Peripheral Neuropathy on the Quality of Life in Cancer Patients
by: Marica Novak, et al.
Published: (2022-01-01)

Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
by: Jennifer M. Mongiovi, et al.
Published: (2018-11-01)

Chronic chemotherapy-induced peripheral neuropathy and pain following paclitaxel versus docetaxel in breast cancer survivors: A cross-sectional study
by: Nina Lykkegaard Gehr, et al.
Published: (2025-04-01)

Transplantation of engineered exosomes derived from bone marrow mesenchymal stromal cells ameliorate diabetic peripheral neuropathy under electrical stimulation
by: Anamika Singh, et al.
Published: (2021-08-01)

Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes
by: Frank vanHaren, et al.
Published: (2022-10-01)

Vitamin E for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: A meta-Analysis
by: Jie Chen, et al.
Published: (2021-05-01)

Exploring Outcome Priorities and Real-Life Management of Chemotherapy-Induced Peripheral Neurotoxicity: A Survey of the Italian Association for the Study of Pain members
by: Sardo S, et al.
Published: (2023-09-01)

Taxane-induced acute interstitial pneumonitis in patients with breast cancer and outcome of taxane rechallenge
by: T M Anoop, et al.
Published: (2022-01-01)

Different Drugs for the Treatment of Painful Diabetic Peripheral Neuropathy: A Meta-Analysis
by: Lian Jingxuan, et al.
Published: (2021-10-01)

Pathological Mechanisms and Preventive Strategies of Oxaliplatin-Induced Peripheral Neuropathy
by: Nobuaki Egashira
Published: (2021-12-01)

Personalised, Rational, Efficacy-Driven Cancer Drug Dosing via an Artificial Intelligence SystEm (PRECISE): A Protocol for the PRECISE CURATE.AI Pilot Clinical Trial
by: Benjamin Kye Jyn Tan, et al.
Published: (2021-04-01)

CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study
by: Laurence McEvoy, et al.
Published: (2023-07-01)

Innovation in cryotherapy after thirty years research in Poland
by: Anna Monika Łysień, et al.
Published: (2019-03-01)

Cold Application and Exercise on Development of Peripheral Neuropathy during Taxane Chemotherapy in Breast Cancer Patients: A Randomized Controlled Trial
by: Neriman Yükseltürk Simsek, et al.
Published: (2021-01-01)

The Efficacy of Neuromodulation Interventions for Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis
by: Xu R, et al.
Published: (2024-04-01)

Effectiveness of cryotherapy in preventing oral mucositis in pediatric cancer patients in Jordan: a randomized controlled trial
by: Khadeja Banat, et al.
Published: (2024-10-01)